Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 7Gynecologic 4Gastrointestinal 4Thoracic 3Genitourinary 3NET 2Head & Neck 2Endocrine 2Dermatologic 2CNS 2Breast 2Other solid neoplasm 1Other 1

Conditions

Obesity 60Neoplasms 20Overweight 17Polycystic Ovary Syndrome 11Dyspnea 10Sexual Dysfunction, Physiological 9Prostatic Neoplasms 7Motor Activity 7Hypertension 7Endometrial Neoplasms 7Breast Neoplasms 7Diabetes Mellitus, Type 2 6Mucositis 5Metabolic Syndrome 5Diabetes Mellitus 5Pulmonary Disease, Chronic Obstructive 4Lung Neoplasms 4Depression 4Constipation 4Cardiovascular Diseases 4Weight Loss 3Stomatitis 3Renal Insufficiency, Chronic 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Opioid-Induced Constipation 3Non-alcoholic Fatty Liver Disease 3Myasthenia Gravis 3Insulin Resistance 3Heart Failure 3Endometrial Hyperplasia 3

Interventions

atezolizumab 1TIC10 compound 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinosarcoma × Other × Clear all
NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
58 enrolled
GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡